Neuropathological assessment of Parkinson's disease

refining the diagnostic criteria

Dennis W Dickson, Heiko Braak, John E. Duda, Charles Duyckaerts, Thomas Gasser, Glenda M. Halliday, John Hardy, James B. Leverenz, Kelly Del Tredici, Zbigniew K Wszolek, Irene Litvan

Research output: Contribution to journalArticle

390 Citations (Scopus)

Abstract

To date, there have been few systematic attempts to provide a standard operating procedure for the neuropathological diagnosis of Parkinson's disease (PD). Pathological examination cannot classify the clinical syndrome with certainty; therefore, the neuropathological diagnosis is, at best, a probability statement. The neuropathological diagnosis of parkinsonism has become increasingly based on fundamental molecular underpinnings, with recognition that the genetics of parkinsonism is heterogeneous and includes disorders that are associated with and without Lewy bodies. The advent of α-synuclein immunohistochemistry has substantially improved the ability to identify Lewy pathology, particularly cortical Lewy bodies and smaller aggregates within processes and the neuropil. In this Review we discuss the diagnostic criteria for the neuropathological assessment of PD. These criteria are provisional and need to be validated through an iterative process that could help with their refinement. Additionally, we suggest future directions for neuropathology research on PD.

Original languageEnglish (US)
Pages (from-to)1150-1157
Number of pages8
JournalThe Lancet Neurology
Volume8
Issue number12
DOIs
StatePublished - Dec 2009

Fingerprint

Parkinson Disease
Lewy Bodies
Parkinsonian Disorders
Synucleins
Neuropil
Immunohistochemistry
Pathology
Research
Direction compound
Neuropathology

ASJC Scopus subject areas

  • Clinical Neurology

Cite this

Dickson, D. W., Braak, H., Duda, J. E., Duyckaerts, C., Gasser, T., Halliday, G. M., ... Litvan, I. (2009). Neuropathological assessment of Parkinson's disease: refining the diagnostic criteria. The Lancet Neurology, 8(12), 1150-1157. https://doi.org/10.1016/S1474-4422(09)70238-8

Neuropathological assessment of Parkinson's disease : refining the diagnostic criteria. / Dickson, Dennis W; Braak, Heiko; Duda, John E.; Duyckaerts, Charles; Gasser, Thomas; Halliday, Glenda M.; Hardy, John; Leverenz, James B.; Del Tredici, Kelly; Wszolek, Zbigniew K; Litvan, Irene.

In: The Lancet Neurology, Vol. 8, No. 12, 12.2009, p. 1150-1157.

Research output: Contribution to journalArticle

Dickson, DW, Braak, H, Duda, JE, Duyckaerts, C, Gasser, T, Halliday, GM, Hardy, J, Leverenz, JB, Del Tredici, K, Wszolek, ZK & Litvan, I 2009, 'Neuropathological assessment of Parkinson's disease: refining the diagnostic criteria', The Lancet Neurology, vol. 8, no. 12, pp. 1150-1157. https://doi.org/10.1016/S1474-4422(09)70238-8
Dickson, Dennis W ; Braak, Heiko ; Duda, John E. ; Duyckaerts, Charles ; Gasser, Thomas ; Halliday, Glenda M. ; Hardy, John ; Leverenz, James B. ; Del Tredici, Kelly ; Wszolek, Zbigniew K ; Litvan, Irene. / Neuropathological assessment of Parkinson's disease : refining the diagnostic criteria. In: The Lancet Neurology. 2009 ; Vol. 8, No. 12. pp. 1150-1157.
@article{d96f5f464e6141b7b5ba23c016c9dbd0,
title = "Neuropathological assessment of Parkinson's disease: refining the diagnostic criteria",
abstract = "To date, there have been few systematic attempts to provide a standard operating procedure for the neuropathological diagnosis of Parkinson's disease (PD). Pathological examination cannot classify the clinical syndrome with certainty; therefore, the neuropathological diagnosis is, at best, a probability statement. The neuropathological diagnosis of parkinsonism has become increasingly based on fundamental molecular underpinnings, with recognition that the genetics of parkinsonism is heterogeneous and includes disorders that are associated with and without Lewy bodies. The advent of α-synuclein immunohistochemistry has substantially improved the ability to identify Lewy pathology, particularly cortical Lewy bodies and smaller aggregates within processes and the neuropil. In this Review we discuss the diagnostic criteria for the neuropathological assessment of PD. These criteria are provisional and need to be validated through an iterative process that could help with their refinement. Additionally, we suggest future directions for neuropathology research on PD.",
author = "Dickson, {Dennis W} and Heiko Braak and Duda, {John E.} and Charles Duyckaerts and Thomas Gasser and Halliday, {Glenda M.} and John Hardy and Leverenz, {James B.} and {Del Tredici}, Kelly and Wszolek, {Zbigniew K} and Irene Litvan",
year = "2009",
month = "12",
doi = "10.1016/S1474-4422(09)70238-8",
language = "English (US)",
volume = "8",
pages = "1150--1157",
journal = "The Lancet Neurology",
issn = "1474-4422",
publisher = "Lancet Publishing Group",
number = "12",

}

TY - JOUR

T1 - Neuropathological assessment of Parkinson's disease

T2 - refining the diagnostic criteria

AU - Dickson, Dennis W

AU - Braak, Heiko

AU - Duda, John E.

AU - Duyckaerts, Charles

AU - Gasser, Thomas

AU - Halliday, Glenda M.

AU - Hardy, John

AU - Leverenz, James B.

AU - Del Tredici, Kelly

AU - Wszolek, Zbigniew K

AU - Litvan, Irene

PY - 2009/12

Y1 - 2009/12

N2 - To date, there have been few systematic attempts to provide a standard operating procedure for the neuropathological diagnosis of Parkinson's disease (PD). Pathological examination cannot classify the clinical syndrome with certainty; therefore, the neuropathological diagnosis is, at best, a probability statement. The neuropathological diagnosis of parkinsonism has become increasingly based on fundamental molecular underpinnings, with recognition that the genetics of parkinsonism is heterogeneous and includes disorders that are associated with and without Lewy bodies. The advent of α-synuclein immunohistochemistry has substantially improved the ability to identify Lewy pathology, particularly cortical Lewy bodies and smaller aggregates within processes and the neuropil. In this Review we discuss the diagnostic criteria for the neuropathological assessment of PD. These criteria are provisional and need to be validated through an iterative process that could help with their refinement. Additionally, we suggest future directions for neuropathology research on PD.

AB - To date, there have been few systematic attempts to provide a standard operating procedure for the neuropathological diagnosis of Parkinson's disease (PD). Pathological examination cannot classify the clinical syndrome with certainty; therefore, the neuropathological diagnosis is, at best, a probability statement. The neuropathological diagnosis of parkinsonism has become increasingly based on fundamental molecular underpinnings, with recognition that the genetics of parkinsonism is heterogeneous and includes disorders that are associated with and without Lewy bodies. The advent of α-synuclein immunohistochemistry has substantially improved the ability to identify Lewy pathology, particularly cortical Lewy bodies and smaller aggregates within processes and the neuropil. In this Review we discuss the diagnostic criteria for the neuropathological assessment of PD. These criteria are provisional and need to be validated through an iterative process that could help with their refinement. Additionally, we suggest future directions for neuropathology research on PD.

UR - http://www.scopus.com/inward/record.url?scp=71849092190&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=71849092190&partnerID=8YFLogxK

U2 - 10.1016/S1474-4422(09)70238-8

DO - 10.1016/S1474-4422(09)70238-8

M3 - Article

VL - 8

SP - 1150

EP - 1157

JO - The Lancet Neurology

JF - The Lancet Neurology

SN - 1474-4422

IS - 12

ER -